We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 501.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMDC
RNS Number : 3351P
Mediclinic International PLC
16 November 2016
Mediclinic International PLC (the "Company")
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
16 November 2016
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
AND PERSONS CLOSELY ASSOCIATED WITH THEM
1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------ a) Name Daniël Petrus Meintjes --- --------------------- ------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------ a) Position Chief Executive Officer of the / status Company --- --------------------- ------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- ------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------ a) Name Mediclinic International plc --- ----------------------- ----------------------------------- b) LEI N/A --- ----------------------- ----------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------ a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- ------------------------------------- b) Nature of Acquisition the transaction --- --------------------- ------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) --------------------- ---------- ZAR133.84 per share 2,200 --------------------- ---------- --- --------------------- ------------------------------------- d) Aggregated N/A information Aggregated volume Price --- --------------------- ------------------------------------- e) Date of the 15 November 2016 transaction --- --------------------- ------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- -------------------------------------
Registered address: 1(st) Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBGBDBGUBBGLL
(END) Dow Jones Newswires
November 16, 2016 07:00 ET (12:00 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions